Search results
Merck to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Morningstar· 2 days agoMerck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and chief executive officer, and Dr. Dean Y. Li, executive ...
Moderna, Merck shares rise as combined melanoma therapy shows improved survival rate By...
Investing.com· 4 days agoModerna (NASDAQ:MRNA) and Merck (MRK) have released new, more encouraging three-year data on their...
Promising trial data for Moderna-Merck skin cancer vaccine sends stock rising
Quartz· 3 days agoModerna stock jumped nearly 4% on Tuesday after the the company announced positive data from an...
Analyst Report: Merck & Co Inc
Argus Research via Yahoo Finance· 2 days agoMerck & Co. is a worldwide pharmaceutical company. Its major drugs include treatments in oncology and diabetes. The company also has a leading vaccine business and an animal health division. MRK shares are included in the S&P 500.
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 4 days agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Arizona Daily Sun· 4 days agoModerna and partner Merck & Co said on Monday their cancer vaccine in combination with blockbuster...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 4 days ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga· 4 days agoMonday, Moderna Inc MRNA and Merck & Co Inc MRK announced the first presentation of results from a planned analysis from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study. The ...
ASCO 2024: What's New in Breast Cancer Research?
Medscape· 1 day agoDrs Alexandra Thomas and Virginia Kaklamani discuss highlights in breast cancer research from the ASCO 2024 Annual Meeting.
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via AOL· 4 days agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
